Weiqing Wang
Corporate finance and investor relations associate at Actinium Pharmaceuticals, Inc.- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
0
/5.0 / Based on 0 ratingsFilter reviews by:
Credentials
-
Fellowship Completion
The Data IncubatorDec, 2020- Sep, 2024 -
Columbia University Fintech Certification Program
Columbia University School of Professional StudiesJan, 2020- Sep, 2024 -
Investment Strategies and Portfolio Analysis
Coursera Course CertificatesJun, 2019- Sep, 2024 -
Biases and Portfolio Selection
Coursera Course CertificatesMay, 2019- Sep, 2024 -
Portfolio Selection and Risk Management
Coursera Course CertificatesMay, 2019- Sep, 2024 -
Global Financial Markets and Instruments
Coursera Course CertificatesApr, 2019- Sep, 2024 -
Chartered Financial Analyst (CFA) level II candidate
CFA InstituteDec, 2018- Sep, 2024
Experience
-
Actinium Pharmaceuticals, Inc.
-
United States
-
Biotechnology Research
-
1 - 100 Employee
-
Corporate finance and investor relations associate
-
Jun 2021 - Present
-
-
-
The Data Incubator
-
United States
-
Higher Education
-
1 - 100 Employee
-
Data Science Fellow
-
Sep 2020 - Nov 2020
• An intensive data science training program with an acceptance rate of 3% • Weekly projects: identified popular celebrities by scraping more than 1,200 webpages from New York Social Diary website and constructed social network using NetworkX; predicted Yelp ratings with features extracted from 30,000 Yelp reviews using scikit-learn; analyzed more than 500,000 records of restaurant inspection data using SQL; analyzed Stack Exchange data using PySpark • Capstone project: compared beauty products’ ingredients using PCA and cosine similarity; built a web application visualizing the data using Altair, HTML, JavaScript and Flask Show less
-
-
-
Icahn School of Medicine at Mount Sinai
-
United States
-
Hospitals and Health Care
-
700 & Above Employee
-
Eli Stahl Lab Graduate Student
-
Jul 2016 - Oct 2020
• Preprocess and perform quality control of exome sequencing data of 1,000 bipolar patients; remove outliers using PCA based on samples' genetic profile and adjust for batch effect to make case and control groups more comparable using an mahalanobis distance • Evaluate the genetic burden using logistic regression model • Manuscript submitted to Molecular Psychiatry, a biology journal with an impact factor of 12 • Preprocess and perform quality control of exome sequencing data of 1,000 bipolar patients; remove outliers using PCA based on samples' genetic profile and adjust for batch effect to make case and control groups more comparable using an mahalanobis distance • Evaluate the genetic burden using logistic regression model • Manuscript submitted to Molecular Psychiatry, a biology journal with an impact factor of 12
-
-
-
The Solution Lab, Inc.
-
United States
-
Think Tanks
-
1 - 100 Employee
-
Equity Research Associate
-
Jan 2020 - Mar 2020
• Read 10+ scientific literatures and prepared 6-page scientific writings on gene therapy methods, with writings later internally published in the investment bank • Summarized company pipelines, business strategies and research results for four gene therapy companies • Read 10+ scientific literatures and prepared 6-page scientific writings on gene therapy methods, with writings later internally published in the investment bank • Summarized company pipelines, business strategies and research results for four gene therapy companies
-
-
-
Columbia University in the City of New York
-
Higher Education
-
1 - 100 Employee
-
Bootcamp in FinTech
-
Aug 2019 - Feb 2020
• A 24-week intensive program on data visualization, machine learning and blockchain • Identified the top 500 outperforming stocks in the next month using a rolling 12-month window of technical and fundamental metrics • Built three machine learning models (gradient boosting, random forecast, neural network) to predict the probability of outperformance against S&P 500 index • Gradient boosting model was chosen based on the superior precision score and excess return (25%) • A 24-week intensive program on data visualization, machine learning and blockchain • Identified the top 500 outperforming stocks in the next month using a rolling 12-month window of technical and fundamental metrics • Built three machine learning models (gradient boosting, random forecast, neural network) to predict the probability of outperformance against S&P 500 index • Gradient boosting model was chosen based on the superior precision score and excess return (25%)
-
-
-
-
Bioinformatics Summer Intern
-
Jul 2019 - Sep 2019
• Singlehandedly built an analysis pipeline for next generation sequencing data from scratch • Used various bioinformatics tools to predict tumor-specific epitopes for personalized cancer treatment • Singlehandedly built an analysis pipeline for next generation sequencing data from scratch • Used various bioinformatics tools to predict tumor-specific epitopes for personalized cancer treatment
-
-
-
Alpha Capital Holdings, Inc.
-
United States
-
Investment Banking
-
1 - 100 Employee
-
Equity Research Summer Intern
-
Apr 2019 - May 2019
• Evaluated Illumina company’s stock value using DCF model and three financial statements • Conducted deep dive research on Illumina that includes competitive landscape, existing technology assessment and industry overview and wrote one-page stock pitch that advises a buy on the stock based on the company’s dominance in the DNA sequencing market and the fast growing genetic testing industry • Evaluated Illumina company’s stock value using DCF model and three financial statements • Conducted deep dive research on Illumina that includes competitive landscape, existing technology assessment and industry overview and wrote one-page stock pitch that advises a buy on the stock based on the company’s dominance in the DNA sequencing market and the fast growing genetic testing industry
-
-
-
-
-
Jul 2015 - Sep 2015
Worked on multi-omics data from asthma patients. From identifying differentially expressed genes and constructing co-expression networks in lung tissue to processing whole genome sequencing data and identifying eQTLs, gained a variety of bioinformatics skills.
-
-
-
Apr 2015 - Jun 2015
Worked on data mining on Gene Expression Omnibus (GEO) to generate disease signatures for Amyotrophic Lateral Sclerosis and Huntington's Disease. Worked on making a web application that can perform meta-analysis of gene expression from collected disease data.
-
-
-
Dec 2014 - Mar 2015
Worked on making recombinant adeno-associated virus (AAV) as a vehicle for gene delivery. Successfully made the recombinant virus by the end of the rotation.
-
-
-
Bard College
-
United States
-
Higher Education
-
700 & Above Employee
-
-
Feb 2011 - May 2013
Have been trying to develop potential novel antibiotic that works by interacting with the riboswitch region of mRNA. Presented the results at Mid-Hudson ACS Undergraduate Chemistry Research Symposium.
-
-
-
Jan 2013 - Feb 2013
Taught and coached middle school students various scientific experiments.
-
-
-
Georgia Regents University
-
Higher Education
-
Biomedical Research Intern
-
May 2011 - Jul 2011
Worked in a zebrafish lab that investigates retina regeneration. Worked in a zebrafish lab that investigates retina regeneration.
-
-
Education
-
Icahn School of Medicine at Mount Sinai
Doctor of Philosophy (PhD), Computational Biology -
Bard College
Bachelor's degree, Biology, General